Sign in
Taking peopleNo phase

Personalized Estimates of Response and Severity Outcomes in Newly-diagnosed JIA

Key facts

Who runs it
University of British Columbia
Where
Canada1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
842 people, planned
Started
23 May 2023
Expected to end
Feb 2029
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Shared Decision Making (SDM)
Record updated
6 December 2023

Who can take part

Age
1 year to 18 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 17 criteriaShow less

Other criteria

  • Physicians (Inclusion):
  • Licensed to practice pediatric rheumatology in Canada
  • Providing care for children with JIA at least once a month
  • Consent to be randomized and to implement the SDM intervention for the duration of the trial, if randomized to the intervention arm
  • Commit to propose enrollment in the Registry to all their newly diagnosed patients with JIA during the trial; Physicians (Exclusion):
  • Fellows-in-training
  • Physicians planning to retire within 2 years; Patient (Inclusion):
  • Consent to include their information in the CAPRI JIA Registry
  • Consent to the PERSON-JIA trial and answering additional questionnaires to assess decision making
  • Allow recording of their medical encounter (if selected at random)
  • JIA fulfilling International League of Associations for Rheumatology (ILAR) criteria
  • Newly diagnosed (within the last month)
  • Diagnosed by a pediatric rheumatologist participating in the PERSON-JIA study
  • Not yet receiving treatment, or received only Non-Steroidal Anti-Inflammatory Drugs (NSAIDS) or joint injections; Patient (Exclusion):
  • Systemic arthritis category of JIA (it requires a different treatment approach)
  • Family is unable to complete study forms in English or French
  • Patients who have already started systemic corticosteroid or any Disease Modifying Anti-Rheumatic Drug (DMARD)

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 1 and 18 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The PERSON-JIA Trial is a cluster-randomized trial testing the use of Shared Decision Making (SDM) with families for treatment of children with arthritis. The intervention is a discussion between physicians and families at the time of diagnosis that uses computer-generated personalized outcome reports generated by previously developed prediction algorithms.

Read full original descriptionShow less

By using information provided by thousands of families, the investigators have developed a way of providing answers to common questions asked by patients and their families at diagnosis.

We will test whether a structured discussion and shared decision between families and doctors (guided by the patient's personal report) will improve the tailoring of treatment to the child and control of their disease. The personal report is called the PERSON-JIA report and presents the child's expected disease severity, the likelihood the child will be arthritis free by age 18 and the chance treatments will be effective and/or have side effects. This way, answers to these questions can be shared by physicians and families to weigh potential benefits and harms according to family values and preferences.

The investigators expect that using the personalized report in a frank and thoughtful discussion will help physicians and families make better decisions about managing the child's disease. This in turn will result in better disease control, greater family engagement and satisfaction with care and better-tailored treatment. If so, this will be a ground-breaking way of using information provided by families and doctors to improve the care provided to and the outcomes of children with arthritis in Canada.

The 2 groups in the trial

  • Current Best PracticeNo study treatment, for comparison

    Physicians randomized to this arm will provide current care and treatment decisions with patients will be made in accordance with current best practices. Will not engage in structured shared decision making (SDM) discussion and will not have access to PERSON-JIA Reports. Patients will be consented to enroll in the CAPRI Registry at the clinic visit when they are diagnosed. Registry enrollment will allow collection and input of clinical data into the Registry. Clinic visit and discussion will remain unchanged for physicians, patients and their families. Questionnaires will be collected at enrollment, at the second visit and a 6-month and 12-month follow-up visits.

  • Shared Decision Making (SDM)Treatment being tested

    Physicians will use the PERSON-JIA Report to guide discussions with the newly diagnosed patient and family. The intervention will not dictate the use of specific medications or treatment strategies, only facilitate better informed treatment choices according to patient circumstances. The intervention is a structured SDM discussion between physician and family, occurring at the time of the child's JIA diagnosis. Discussion is guided by the PERSON-JIA Report, which is generated in real time, on the physician's smart phone. Patients newly-diagnosed with JIA will be consented to both enrollment in the CAPRI Registry and enrollment in the PERSON-JIA trial. Clinic visit and discussion between the physician, patient and family will be facilitated by the PERSON-JIA report to support a shared decision making process. Questionnaires will be collected at enrollment, at the second visit and at 6-month and 12-month follow-up visits.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Treating Children With Arthritis According to Their Individual Probability of Outcomes and Response to Treatments
Criteria questions
Built from NCT05310799, who can take part
Record updated
6 December 2023